Journal of Pathology and Translational Medicine10.4132/jptm.2018.09.192018526369-377High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant ChemotherapyBobae Shim, Min‐Sun Jin, Ji Hye Moon, In Ae Park, Han Suk Ryu,,
Annals of Oncology10.1093/annonc/mdz097.010201930Supplement_3118PDose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Survival analysisA Kr
Breast Diseases: A Year Book Quarterly10.1016/s1043-321x(07)80278-52007182205Breast Cancer–specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-risk Breast Cancer Patients Treated With High-dose Chemotherapy With Peripheral Blood Stem Cell SupportJ.B. Smerage,
The Breast10.1016/s0960-9776(17)30295-3201732S92ERCC1 expression in metastatic triple negative breast cancer patients treated with platinum-based chemotherapyM. El Baiomy, W. El Kashef, M. El Zafarany,
Journal of Surgical Research10.1016/j.jss.2009.11.19520101582240Neoadjuvant versus Adjuvant Chemotherapy in Patients with Triple Negative Breast Cancer: Predictors of Use and Survival OutcomesC. Kennedy, F. Gao, J.A. Margenthaler,
Triple-Negative Breast Cancer10.1007/978-3-319-69980-6_7201783-94Optimizing Adjuvant and Neoadjuvant Chemotherapy for Triple-Negative Breast CancerSonya Reid-Lawrence, Antoinette R. Tan, Ingrid A. Mayer
The Breast10.1016/j.breast.2015.07.032201524S132-S135Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancerDaniel G. Stover, Eric P. Winer,
The Breast10.1016/j.breast.2017.01.006201736102Have all triple-negative breast cancer patients worse breast cancer-specific survival?Kadri Altundag,
Annals of Oncology10.1093/annonc/mdz095.043201930Supplement_344PPrognostic value of Ki-67 in patients with triple-negative breast cancer receiving neo-adjuvant or adjuvant chemotherapy: A systematic review and meta-analysisQ Zhou, W Li
Cancer Management and Research10.2147/cmar.s1747352018Volume 103801-3808Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapyYuqian Liao, Yulu Liao, Jun Li, Junyu Li, Ying Fan, Binghe Xu,